Skip to main content

Table 3 Metabolites concentrations decreased from T1 to T4

From: Comparison of serum metabolomics in women with breast Cancer Prior to Chemotherapy and at 1 year: cardiometabolic implications

Metabolite Name

Mean Baseline

Mean

Time 4

Baseline vs. Time 4

p

value

Time4/Baseline (Fold Change)

Log FC

Log p Value

Metabolite

M/Z

RT

Polarity

9-OxoODE

807316.8484

213604.3571

4.54E-09

0.264585531

-0.57743391

8.342944147

816

293.21

1.39

N

methyl 9,12-dihydroxy-13-oxo-10-

octadecenoate

240295.5445

106017.2477

7.37E-08

0.441195229

-0.35536919

7.132532512

894

341.23

1.36

 N

(±)4-HDoHE

564089.4378

60787.68784

0.000000476

0.1077625

-0.96753234

6.322393047

811

343.23

1.38

N

3-Hydroxy-10’-apo-b,y-carotenal

8757737.728

4270213.094

0.00000388

0.487593169

-0.31194239

5.411168274

638

391.26

1.36

N

3-HYDROXYPHENYLACETATE

6233095.228

1064125.687

0.00000388

0.170721872

-0.76771084

5.411168274

719

151.04

1.46

P

Sorbitan palmitate

3174643.67

1483053.062

0.0000504

0.467155755

-0.3305383

4.297569464

939

401.29

1.35

N

all-trans-8’-Apo-beta-carotenal

2287016.498

1067706.912

0.000122764

0.466855798

-0.33081724

3.910928969

1051

415.3

1.35

N

Tetracosapentaynoic acid

439102.5801

185276.7118

0.000217585

0.421944029

-0.37474515

3.662371048

1000

347.2

1.41

N

20-carboxy Arachidonic Acid

152672.5204

71023.83458

0.00037903

0.465203786

-0.33235676

3.421326415

9882

335.22

1.38

P

2-Pyrrolidinone, 4-(2-morpholinoethyl)-3,3-diphenyl-

140739.3866

61074.46065

0.005859125

0.43395429

-0.36255601

2.232167237

4133

349.2

1.42

N

5-ethyl-2-nitro-9 h-carbazole

1231036.119

323524.5459

p > 0.05

0.262806705

-0.58036356

0.810493755

6643

239.08

1.84

N

Phenylalanine

247381.9061

119854.5344

p > 0.05

0.484491919

-0.31471346

0.080963844

15,253

166.09

1.47

P